期刊文献+

针刺新吾穴联合鼻鼽汤治疗变应性鼻炎的临床研究 被引量:15

Clinical Study on Acupuncturing Xinwu Point and Biqiu Decoction on Allergic Rhinitis
下载PDF
导出
摘要 目的观察针刺蝶腭神经节联合鼻鼽汤治疗变应性鼻炎的临床疗效。方法患者80例随机分为两组,治疗组给予针刺蝶腭神经节联合鼻鼽汤治疗,对照组给予鼻鼽汤治疗,疗程均为15 d。观察两组治疗前后患者鼻部局部证候积分、中医证候积分、鼻黏膜生活质量量表(RQLQ)评分、IgE、白细胞介素-4(IL-4)、IL-12、IFN-γ水平。结果治疗后患者鼻部局部证候积分、中医证候积分、鼻黏膜生活质量量表(RQLQ)评分、IgE、白细胞介素-4(IL-4)均显著降低,IL-12、IFN-γ均显著增加(P <0.05),治疗组优于对照组(P <0.05)。治疗组总有效率为92.50%,高于对照组的82.50%(P <0.05)。结论针刺蝶腭神经节联合鼻鼽汤治疗变应性鼻炎疗效显著,优于单用鼻鼽汤组。 Objective: To observe the clinical efficacy of acupuncture pterygopalatine combined with Biqiu Decoction on allergic rhinitis. Methods: 80 patients were randomly divided into the control group and the treatment group,40 cases in each. The treatment group was treated with acupuncture pterygopalatine combined with Biqiu Decoction,and the control group was given Biqiu Decoction for 15 days.The patient′s nasal local syndrome scores,TCM syndrome scores,RQLQ nasal mucosal quality of life scale scores,and the levels of IgE,IL-4,IL-12 and IFN-γ were observed before and after treatment. Results: The patient′s nasal local syndrome scores,TCM syndrome scores,RQLQ nasal mucosal quality of life scale scores,IgE and IL-4 dropped significantly;IL-12 and IFN-γ increased significantly after treatment(P < 0.05);the treatment group was superior to the control group(P < 0.05). The total effective rate was 92.50% in the treatment group,higher than 82.50% in the control group(P < 0.05). Conclusion: Acupuncture pterygopalatine combined with Biqiu Decoction is effective on allergic rhinitis,better than single Biqiu Decoction.
作者 张乃楠 马莉 Zhang Nainan;Ma Li(Heilong jiang University of Chinese Medicine,Heilongjiang,Harbin 150040,China)
出处 《中国中医急症》 2019年第5期766-769,共4页 Journal of Emergency in Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81874495)
关键词 变应性鼻炎 针刺 蝶腭神经节 鼻鼽汤 Allergic rhinitis Acupuncture Pterygopalatine Biqiu Decoction
  • 相关文献

参考文献15

二级参考文献263

共引文献2916

同被引文献234

引证文献15

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部